LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

LLY

749.85

+1.61%↑

JNJ

177.08

-0.6%↓

ABBV

210.45

+0.22%↑

UNH

348.61

+8.84%↑

NVO

54.26

-0.09%↓

Search

HealthStream Inc

Slēgts

SektorsVeselības aprūpe

28.65 2.21

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

27.46

Max

28.66

Galvenie mērījumi

By Trading Economics

Ienākumi

1.1M

5.4M

Pārdošana

911K

74M

P/E

Sektora vidējais

41.925

35.664

EPS

0.14

Dividenžu ienesīgums

0.42

Peļņas marža

7.244

Darbinieki

1,083

EBITDA

2.6M

18M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+21.04% upside

Dividendes

By Dow Jones

Dividenžu ienesīgums

Sektora vidējais

0.42%

3.12%

Nākamie ieņēmumi

2025. g. 20. okt.

Nākamais dividenžu datums

2025. g. 14. nov.

Nākamais Ex dividenžu datums

2025. g. 3. dec.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

40M

835M

Iepriekšējā atvēršanas cena

26.44

Iepriekšējā slēgšanas cena

28.65

Ziņu noskaņojums

By Acuity

50%

50%

156 / 371 Rangs Healthcare

Tehniskais rādītājs

By Trading Central

Pārliecība

Very Strong Bearish Evidence

HealthStream Inc Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2025. g. 9. sept. 23:37 UTC

Karstas akcijas

Stocks to Watch: Oracle, Wearable Devices, GameStop

2025. g. 9. sept. 20:41 UTC

Peļņas

Oracle's Backlog Surges With Major Customer Deals in 1Q

2025. g. 9. sept. 20:30 UTC

Peļņas

GameStop 2Q Sales, Profit Rise

2025. g. 9. sept. 23:19 UTC

Tirgus saruna

ANZ Adds a Further 50 Bps in FOMC Cuts to Outlook -- Market Talk

2025. g. 9. sept. 21:35 UTC

Peļņas

Oracle Stock Soars on Strong AI Backlog. Earnings Were Good Enough. -- Barrons.com

2025. g. 9. sept. 21:32 UTC

Peļņas

Oracle's Backlog Swells With Big Customer Deals -- Update

2025. g. 9. sept. 21:02 UTC

Iegādes, apvienošanās, pārņemšana

DHL Adds to Healthcare Logistics Services With Acquisition -- Update

2025. g. 9. sept. 20:50 UTC

Tirgus saruna

Basic Materials Roundup: Market Talk

2025. g. 9. sept. 20:33 UTC

Peļņas

These Stocks Moved the Most Today: Apple, UnitedHealth, Nebius, Wolfspeed, Tourmaline Bio, Albemarle, Dell, and More -- Barrons.com

2025. g. 9. sept. 20:26 UTC

Peļņas

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

2025. g. 9. sept. 20:23 UTC

Peļņas

Oracle Stock Soars on Strong Backlog. Earnings Were Good Enough. -- Barrons.com

2025. g. 9. sept. 20:12 UTC

Peļņas

Oracle Stock Jumps on Mixed Earnings Report -- Barrons.com

2025. g. 9. sept. 20:10 UTC

Peļņas

Oracle Expects Cloud Infrastructure Rev to Grow 77% to $18 B This Fiscal Yr >ORCL

2025. g. 9. sept. 20:10 UTC

Peļņas

Oracle Expects to Sign-Up Several Additional Multi-B-dollar Customers and RPO Is Likely to Exceed Half-A-Trillion Dollars Over Next Few Mos

2025. g. 9. sept. 20:09 UTC

Peļņas

Synopsys Sees 4Q Adj EPS $2.76-Adj EPS $2.80 >SNPS

2025. g. 9. sept. 20:09 UTC

Peļņas

Synopsys Sees 4Q Loss/Shr 16c-Loss 27c >SNPS

2025. g. 9. sept. 20:08 UTC

Peļņas

Oracle 1Q Short-term Deferred Rev Were $12.1 B >ORCL

2025. g. 9. sept. 20:08 UTC

Peļņas

Oracle 1Q Operating Income Was $4.3 B >ORCL

2025. g. 9. sept. 20:08 UTC

Peļņas

Oracle Expects MultiCloud Rev to Grow Substantially Every Qtr for Several Years >ORCL

2025. g. 9. sept. 20:08 UTC

Peļņas

Synopsys Sees 4Q Rev $2.23B-$2.26B >SNPS

2025. g. 9. sept. 20:07 UTC

Peļņas

Oracle Total Remaining Performance Obligations Up to $455 B >ORCL

2025. g. 9. sept. 20:06 UTC

Peļņas

Oracle 1Q Software Revenue $5.72B >ORCL

2025. g. 9. sept. 20:06 UTC

Peļņas

Synopsys 3Q Adj EPS $3.39 >SNPS

2025. g. 9. sept. 20:06 UTC

Peļņas

Oracle 1Q Cloud Revenue $7.19B >ORCL

2025. g. 9. sept. 20:05 UTC

Peļņas

Oracle 1Q Rev $14.93B >ORCL

2025. g. 9. sept. 20:05 UTC

Peļņas

Oracle 1Q EPS $1.01 >ORCL

2025. g. 9. sept. 20:05 UTC

Peļņas

Synopsys 3Q EPS $1.50 >SNPS

2025. g. 9. sept. 20:05 UTC

Peļņas

Oracle 1Q Services Revenue $1.35B >ORCL

2025. g. 9. sept. 20:05 UTC

Peļņas

Oracle 1Q Adj EPS $1.47 >ORCL

2025. g. 9. sept. 20:05 UTC

Peļņas

Oracle 1Q Hardware Revenue $670M >ORCL

Salīdzinājums

Cenas izmaiņa

HealthStream Inc Prognoze

Cenas mērķis

By TipRanks

21.04% augšup

Prognoze 12 mēnešiem

Vidējais 34 USD  21.04%

Augstākais 40 USD

Zemākais 28 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi HealthStream Inc — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

4 ratings

2

Pirkt

2

Turēt

0

Pārdot

Tehniskais rādītājs

By Trading Central

26.82 / 33.21Atbalsts un pretestība

Īstermiņā

Very Strong Bearish Evidence

Vidējā termiņā

Bearish Evidence

Ilgtermiņā

Bearish Evidence

Noskaņojums

By Acuity

156 / 371 Rangs Veselības aprūpe

Ziņu noskaņojums

Neutral

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Zem vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par HealthStream Inc

HealthStream, Inc. provides Software-as-a-Service (SaaS) based applications for healthcare organizations in the United States. The company's solutions help healthcare organizations in meeting their ongoing clinical development, talent management, training, education, assessment, competency management, safety and compliance, and scheduling, as well as provider credentialing, privileging, and enrollment needs. It offers hStream, a technology platform that powers a range of healthcare workforce solutions. The company provides its solutions to customers across a range of entities within the healthcare industry, including private, not-for-profit, and government entities, as well as pharmaceutical and medical device companies through its direct sales teams. The company was incorporated in 1990 and is headquartered in Nashville, Tennessee.
help-icon Live chat